NCT06522308

Brief Summary

Researchers aim to determine the exact prevalence and risk factors for the association of gallstones and umbilical hernia. Umbilical hernia is defined according to the European Hernia Society Classification for primary and incisional abdominal wall hernias as hernias occurring from 3 cm above to 3 cm below the umbilicus. The main outcome measures are the presence of gallstones in patients presenting with umbilical hernia and the presence of umbilical hernia in patients diagnosed with gallstones. Patients with umbilical hernia are examined with biliary ultrasound, while patients with cholelithiasis are evaluated for umbilical hernia by physical examination and ultrasound. Factors such as age, gender, body mass index (BMI), family history, comorbidities, tobacco use, parity, and history of multiple pregnancy are analyzed as potential risk factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
278

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 26, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

January 27, 2025

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

July 22, 2024

Last Update Submit

January 22, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Presence of cholelithiasis in umbilical hernia patients

    In umbilical hernia patients, the presence of cholelithiasis is determined by hepatobiliary ultrasound.

    2 days

  • Presence of umbilical hernia in cholelithiasis patients

    In patients with cholelithiasis, the presence of umbilical hernias is determined by superficial tissue ultrasound of the umbilical region.

    2 days

Secondary Outcomes (3)

  • Body mass index

    2 days

  • The female-male ratio

    2 days

  • Concomitant diseases ratio

    2 days

Study Arms (2)

Cholelithiasis Group

It is determined whether there is an umbilical hernias in patients with cholelithiasis

Diagnostic Test: Umbilical region superficial tissue ultrasound

Umbilical Hernia Group

It is determined whether patients with umbilical hernia have cholelithiasis or not.

Diagnostic Test: Hepatobiliary ultrasound

Interventions

The presence of cholelithiasis in patients with umbilical hernia is detected by hepatobiliary ultrasound

Umbilical Hernia Group

The presence of umbilical hernia in patients with cholelithiasis is detected by ultrasound of the superficial tissue of the umbilical region.

Cholelithiasis Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All female and male cholelithiasis patients and umbilical hernia patients over the age of 18 who applied during the research period constitute the study population.

You may qualify if:

  • Patients with umbilical hernia
  • Patients with cholelithiasis

You may not qualify if:

  • Having previously had surgery for an umbilical hernia
  • Having undergone abdominal surgery with a median line incision
  • having collagen tissue disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya Training and Research Hospital

Konya, 42090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hernia, UmbilicalCholelithiasis

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, VentralHernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsBiliary Tract DiseasesDigestive System Diseases

Study Officials

  • Alpaslan Sahin, MD

    Konya Meram State Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 22, 2024

First Posted

July 26, 2024

Study Start

October 1, 2023

Primary Completion

August 31, 2024

Study Completion

September 30, 2024

Last Updated

January 27, 2025

Record last verified: 2024-10

Locations